Squamous Cell Carcinoma of the Head and Neck (SCCHN)

DBCOND0035874Neoplasms

Squamous Cell Carcinoma of the Head and Neck (SCCHN) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Squamous Neck Carcinoma of the Head and Neck Cancer (SCCHN) · Squamous Cell Carcinoma of Head and Neck · Head and Neck Squamous Cell Carcinoma · Carcinoma, Squamous Cell of Head and Neck · Squamous Cell Head and Neck Carcinoma
Classified under: Neoplasms
Indicated drugs: Methotrexate

Resolves to

Vocabularies

MeSHM0530036SNOMED CT716659002MedDRA10060121UMLSC1168401

What you can answer from here — as of September 27, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

1,575Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Squamous Cell Carcinoma of the Head and Neck (SCCHN) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account